Literature DB >> 16767208

Anterior segment ischaemia with giant cell arteritis.

Elisabeth McKillop1, Deepak Tejwani, Cliff Weir, Jeffery Jay.   

Abstract

CASE REPORT: A 69-year-old male presented with bilateral blurred vision, left periocular pain, and headache. Ocular examination revealed a right optic neuropathy and left anterior segment ischaemia. An elevated erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) raised suspicion of giant cell arteritis (GCA), which was confirmed by temporal artery biopsy. Treatment with intravenous methylprednisolone followed by a gradually reducing dose of oral prednisolone improved vision in both eyes. COMMENTS: GCA typically affects large- and medium-sized vessels. It is a recognised cause of anterior ischaemic optic neuropathy. Anterior segment ischaemia is usually caused by disease of the anterior ciliary arteries not typically affected by GCA. This case illustrates that GCA can rarely cause anterior segment ischaemia, without posterior segment involvement in the same eye.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16767208     DOI: 10.1139/I06-009

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


  3 in total

Review 1.  Giant cell arteritis: ophthalmic manifestations of a systemic disease.

Authors:  Elisabeth De Smit; Eoin O'Sullivan; David A Mackey; Alex W Hewitt
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-08-05       Impact factor: 3.117

2.  A 71-year-old man with bilateral vision loss.

Authors:  Katy C Liu; Jullia A Rosdahl; Mays A El-Dairi
Journal:  Digit J Ophthalmol       Date:  2017-09-03

3.  Giant Cell Arteritis: The Experience of Two Collaborative Referral Centers and an Overview of Disease Pathogenesis and Therapeutic Advancements.

Authors:  Rosanna Dammacco; Giovanni Alessio; Ermete Giancipoli; Patrizia Leone; Anna Cirulli; Leonardo Resta; Angelo Vacca; Franco Dammacco
Journal:  Clin Ophthalmol       Date:  2020-03-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.